Form 8-K - Current report:
SEC Accession No. 0001558370-25-008984
Filing Date
2025-06-30
Accepted
2025-06-30 06:59:26
Documents
44
Period of Report
2025-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20250630x8k.htm   iXBRL 8-K 39449
2 EX-99.1 acrs-20250630xex99d1.htm EX-99.1 47756
3 GRAPHIC acrs-20250630xex99d1g001.jpg GRAPHIC 134865
4 GRAPHIC acrs-20250630xex99d1g002.jpg GRAPHIC 347017
5 GRAPHIC acrs-20250630xex99d1g003.jpg GRAPHIC 215746
6 GRAPHIC acrs-20250630xex99d1g004.jpg GRAPHIC 121254
7 GRAPHIC acrs-20250630xex99d1g005.jpg GRAPHIC 118961
8 GRAPHIC acrs-20250630xex99d1g006.jpg GRAPHIC 92859
9 GRAPHIC acrs-20250630xex99d1g007.jpg GRAPHIC 163165
10 GRAPHIC acrs-20250630xex99d1g008.jpg GRAPHIC 127470
11 GRAPHIC acrs-20250630xex99d1g009.jpg GRAPHIC 140796
12 GRAPHIC acrs-20250630xex99d1g010.jpg GRAPHIC 130440
13 GRAPHIC acrs-20250630xex99d1g011.jpg GRAPHIC 126265
14 GRAPHIC acrs-20250630xex99d1g012.jpg GRAPHIC 143953
15 GRAPHIC acrs-20250630xex99d1g013.jpg GRAPHIC 113733
16 GRAPHIC acrs-20250630xex99d1g014.jpg GRAPHIC 123103
17 GRAPHIC acrs-20250630xex99d1g015.jpg GRAPHIC 136141
18 GRAPHIC acrs-20250630xex99d1g016.jpg GRAPHIC 96888
19 GRAPHIC acrs-20250630xex99d1g017.jpg GRAPHIC 88173
20 GRAPHIC acrs-20250630xex99d1g018.jpg GRAPHIC 142642
21 GRAPHIC acrs-20250630xex99d1g019.jpg GRAPHIC 112797
22 GRAPHIC acrs-20250630xex99d1g020.jpg GRAPHIC 105297
23 GRAPHIC acrs-20250630xex99d1g021.jpg GRAPHIC 58806
24 GRAPHIC acrs-20250630xex99d1g022.jpg GRAPHIC 102751
25 GRAPHIC acrs-20250630xex99d1g023.jpg GRAPHIC 130913
26 GRAPHIC acrs-20250630xex99d1g024.jpg GRAPHIC 146224
27 GRAPHIC acrs-20250630xex99d1g025.jpg GRAPHIC 116678
28 GRAPHIC acrs-20250630xex99d1g026.jpg GRAPHIC 111943
29 GRAPHIC acrs-20250630xex99d1g027.jpg GRAPHIC 105027
30 GRAPHIC acrs-20250630xex99d1g028.jpg GRAPHIC 73503
31 GRAPHIC acrs-20250630xex99d1g029.jpg GRAPHIC 152697
32 GRAPHIC acrs-20250630xex99d1g030.jpg GRAPHIC 148868
33 GRAPHIC acrs-20250630xex99d1g031.jpg GRAPHIC 134585
  Complete submission text file 0001558370-25-008984.txt   5781175

Data Files

Seq Description Document Type Size
34 EX-101.SCH acrs-20250630.xsd EX-101.SCH 3464
35 EX-101.LAB acrs-20250630_lab.xml EX-101.LAB 15918
36 EX-101.PRE acrs-20250630_pre.xml EX-101.PRE 10225
46 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20250630x8k_htm.xml XML 4840
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 251088719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)